Company News /
by Rachael Jones -
4 years ago
06 May 2020 - Mesoblast (ASX:MSB) today announced that the first patients have been dosed in the 300-patient randomized placebo-controlled Phase 2/3 trial in the United States of M…
Market Reports /
by Rachael Jones -
4 years ago
09 Apr 2020 - The ASX saw a rally in late afternoon trade closing on a 4 week high at 3.5% higher. Perenti Global (ASX:PRN) shares advanced over 27% and shares in Commonwealth Bank…
Company News /
by Rachael Jones -
4 years ago
09 Apr 2020 - Mesoblast (ASX:MSB) today announced that its stem cell product candidate remestemcel-L will be formally evaluated in a randomized, placebo-controlled trial in patient…
Market Reports /
by Ortenzia Borre -
4 years ago
10 Mar 2020 - The Australian share market closed 3.1 per cent higher at the end of today’s session. Investors were buying up Energy stocks today with Viva Energy Group (ASX:VEA) le…
Market Reports /
by Ortenzia Borre -
4 years ago
10 Mar 2020 - The Australian share market opened lower again this morning dropping 0.4 per cent by noon. Overnight, the Dow entered into an emergency 15 minute trading halt to prev…
Stock Watch /
by Michael Gable -
4 years ago
20 Jan 2020 - Fairmont Equities Managing Director Michael Gable takes a technical look at why the Aussie share market has more upside
Company News /
by Katrina Bullock -
4 years ago
02 Jan 2020 - Cellular medicinal provider, Mesoblast (ASX:MSB, NASDAQ:MESO) has lodged positive clinical efficacy and safety data with the US FDA for its lead product candidate, re…
Market Reports /
by Rachael Jones -
4 years ago
03 Oct 2019 - It has been a disappointing day of trade for the ASX. After opening in the black the local bourse failed to gain momentum to close 2.2% lower. Ooh!Media (ASX:OML) dro…
Company News /
by Ortenzia Borre -
4 years ago
03 Oct 2019 - Leader in cellular medicines for inflammatory diseases, Mesoblast (ASX:MSB) has successfully completed a $75 million capital raising.
Company News /
by Rachael Jones -
4 years ago
30 Jul 2019 - Mesoblast (ASX:MSB) today reported its operational highlights for their fourth quarter showing growth in revenues achieved by their Japanese partner in the treatment …
Market Reports /
by Jessica Amir -
4 years ago
18 Jun 2019 - The local share market bounces back from yesterday’s fall, rising 0.4% at noon with most sectors charging higher. Property prices fall 3% in March Qtr, more than 2.5%…
Company News /
by Anna Napoli -
4 years ago
11 Jun 2019 - Mesoblast (ASX:MSB) has today announced it has expanded its partnership with JCR Pharmaceuticals in Japan (to the use of mesenchymal stem cells (MSCs)) for the treatm…
Company News /
by Rachael Jones -
5 years ago
27 Mar 2019 - Mesoblast (ASX:MSB) today announced that the International Center for Health Outcomes and Innovation Research have entered into a MoU for a clinical trial using Mesob…
Company News /
by Anna Napoli -
5 years ago
14 Jan 2019 - Mesoblast (ASX:MSB) has today announced it has drawn down (a further) $15 million from its US$75 million four-year credit facility with Hercules Capital.
Market Reports /
by Rachael Jones -
5 years ago
07 Jan 2019 - The ASX has continued to rise throughout this morning after the US posted solid gains on Friday after a boost from impressive employment data from all jobs except far…
Market Reports /
by Rachael Jones -
5 years ago
28 Dec 2018 - It has been a positive day of trade for the Australian share market as the market closed in positive territory. Most of this week's gains came on Thursday. The big fo…
Company News /
by Rachael Jones -
5 years ago
28 Dec 2018 - Mesoblast (ASX:MSB) today released their corporate review showing how the company will enter 2019 with the most mature cell therapy product pipeline and technology pl…
Market Reports /
by Jessica Amir -
5 years ago
19 Dec 2018 - Mid-session report. ASX continues to slide on oil slipping further amid less oil demand. Inghams Group's (ASX:ING) Joel Thickins to retire, its shares trade 26% highe…
Market Reports /
by Rachael Jones -
5 years ago
16 Nov 2018 - The ASX is set to open higher amid optimism that China and the US are seeking to resolve their trade spat. Wall St had a rollercoaster of a day. US stocks rose for th…
Company News /
by Rachael Jones -
5 years ago
12 Oct 2018 - Regenerative medicine comapny Mesoblast (ASX:MSB) today announced completion of the transaction with Tasly Pharmaceutical Group to establish a strategic partnership i…
Market Reports /
by Jessica Amir -
5 years ago
02 Oct 2018 - Market at Midday. ASX200 wipes out 3 months of gains and takes the market back to June levels. Rates to hold for 25th time. Most sectors lower. Mesoblast down 9.4% de…
Company Presentations /
by -
5 years ago
22 Aug 2018 - Mesoblast Limited (ASX:MSB) Head of Business Development and Licensing, David Oxley, presents details about the company's Phase 3 trials, its agreement with Tasly Chi…
Interviews /
by Rachael Jones -
5 years ago
22 Aug 2018 - Mesoblast Limited (ASX:MSB) Head, Business Development and Licensing, David Oxley, discusses the company's Phase 3 trials, its agreement with Tasly China and the near…